MS4A2 and nasal cavity polyp: 1; 95% CI = 1.9–112.17), IKZF2 rs12619285-AA (OR = 9.10; 95% CI = 1.7–75.78), FCER1B rs1441586-C (OR = 7.81; 95% CI = 1.16–73.45), and the presence of nasal polyps (OR = 9.16; 95% CI = 1.58–91.4) (Table 4).